23rd Mar 2007 07:01
MDY Healthcare PLC23 March 2007 MDY Healthcare plc invests in Allergy Therapeutics plc 23rd March 2007 - MDY Healthcare plc, the strategic investor in healthcarecompanies, today announces that it has acquired 500,000 ordinary shares inAllergy Therapeutics plc (AIM: AGY). Allergy Therapeutics is a Europe-based specialty pharmaceutical company focusedupon the treatment and prevention of allergy. It has an existing sales base, anMHRA-approved manufacturing capability and an established sales and marketinginfrastructure in several major European markets. In addition, the company hasa number of novel compounds, which have already undergone initial clinicalevaluation and once registered, could potentially revolutionise the treatment ofallergy. Allergy Therapeutics began dosing patients in January in what is theworld's first global Phase III allergy vaccine development programme. Commenting on the investment, Charles Spicer, CEO of MDY Healthcare, said: "We have been following Allergy Therapeutics' progress for some time and believethe company and its products have significant market potential. With its clearfocus in a specialised high-value area and an international perspective, thecompany fits our profile as a strategic investment within our growingportfolio." For further information, please contact: MDY Healthcare plcCharles Spicer, CEO+44 (0) 207 647 [email protected] Financial DynamicsBen Atwell+44 (0) 207 831 [email protected] [email protected] Notes for editors: About MDY Healthcare MDY Healthcare plc is a sector specialised strategic investing company quoted onAIM (ticker symbol: MDY). MDY Healthcare seeks to achieve superior returns forshareholders by investing globally in companies, both public and private, acrossthe healthcare sector. The directors, executives and senior advisors havesignificant operational and investment experience in the sector and thereforethe ability to identify and review a wide range of potential investments. Further information can be found on the website www.mdyhealthcare.com This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Allergy Thera.